))
Breaking Barriers in Pain Management and ADHD Treatment with Tris Pharma James Hackworth
Manage episode 422763104 series 3563546
Το περιεχόμενο παρέχεται από το Donald Davis, PhD and Don Davis. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Donald Davis, PhD and Don Davis ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
In this episode of the Lifescience Success Podcast, host Don Davis interviews James Hackworth, who shares insights about his background in physics and his journey into the life science industry. James discusses his experiences from McKinsey up to his current role at Tris Pharma, focusing on their innovative drug development and formulation technologies. He dives into the company's advancements in ADHD medications and an exciting new pain management drugs. Additionally, the conversation highlights the importance of partnerships, technology in drug development, and future industry trends. James provides a fascinating glimpse into the complexities and future of pharmaceuticals.
00:00 Welcome and Introduction 00:08 Impressions of the Bio Conference 00:42 James' Background and Journey into Pharma 03:17 Formation and Growth of Park Therapeutics 04:20 Overview of Tris Pharma 04:41 Tris Pharma's Focus and Innovations 08:00 Challenges and Opportunities in Partnering 10:58 Future of Tris Pharma and the Industry 15:41 In-depth Look at Drugs that are progressing 19:21 Conclusion and Final Thoughts
100 επεισόδια
Μοίρασέ το
